338 related articles for article (PubMed ID: 26192633)
1. Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
Ni WJ; Ding HH; Zhou H; Qiu YY; Tang LQ
Eur J Pharmacol; 2015 Oct; 764():448-456. PubMed ID: 26192633
[TBL] [Abstract][Full Text] [Related]
2. H
Li Y; Li L; Zeng O; Liu JM; Yang J
Ren Fail; 2017 Nov; 39(1):265-272. PubMed ID: 27882817
[TBL] [Abstract][Full Text] [Related]
3. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
4. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017
[TBL] [Abstract][Full Text] [Related]
5. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
Liu W; Zhang X; Liu P; Shen X; Lan T; Li W; Jiang Q; Xie X; Huang H
Eur J Pharmacol; 2010 Jul; 638(1-3):150-5. PubMed ID: 20447389
[TBL] [Abstract][Full Text] [Related]
6. Effects of reduced β2-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice.
Xu J; Wang P; Wang T; Wang M; Chen S; Yu P; Yu D
BMC Cardiovasc Disord; 2014 Sep; 14():114. PubMed ID: 25204377
[TBL] [Abstract][Full Text] [Related]
7. Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy.
Qiu YY; Tang LQ; Wei W
Mol Cell Endocrinol; 2017 Mar; 443():89-105. PubMed ID: 28087385
[TBL] [Abstract][Full Text] [Related]
8. Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.
Wang T; Chen SS; Chen R; Yu DM; Yu P
Int J Clin Exp Pathol; 2015; 8(3):2321-33. PubMed ID: 26045739
[TBL] [Abstract][Full Text] [Related]
9. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.
Zhang H; Yang Y; Wang Y; Wang B; Li R
Drug Des Devel Ther; 2018; 12():89-98. PubMed ID: 29386886
[TBL] [Abstract][Full Text] [Related]
10. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
11. [Effect of berberine on expression of transforming growth factor-beta1 and type IV collagen proteins in mesangial cells of diabetic rats with nephropathy].
Tang L; Lv F; Liu S; Zhang S
Zhongguo Zhong Yao Za Zhi; 2011 Dec; 36(24):3494-7. PubMed ID: 22368864
[TBL] [Abstract][Full Text] [Related]
12. Renoprotective effects of berberine and its potential effect on the expression of β-arrestins and intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in streptozocin-diabetic nephropathy rats.
Tang LQ; Ni WJ; Cai M; Ding HH; Liu S; Zhang ST
J Diabetes; 2016 Sep; 8(5):693-700. PubMed ID: 26531813
[TBL] [Abstract][Full Text] [Related]
13. Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy.
Tang LQ; Wang FL; Zhu LN; Lv F; Liu S; Zhang ST
Mol Biol Rep; 2013 Jun; 40(6):3913-23. PubMed ID: 23266672
[TBL] [Abstract][Full Text] [Related]
14. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.
Ren JJ; Huang TJ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Li RK; Liu LX
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):38-47. PubMed ID: 30243878
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
Huang H; Jiang Y; Mao G; Yuan F; Zheng H; Ruan Y; Wu T
J Sci Food Agric; 2017 Mar; 97(4):1359-1366. PubMed ID: 27363537
[TBL] [Abstract][Full Text] [Related]
17. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
18. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
[TBL] [Abstract][Full Text] [Related]
19. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
McLennan SV; Kelly DJ; Cox AJ; Cao Z; Lyons JG; Yue DK; Gilbert RE
Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.
Qi MY; Kai-Chen ; Liu HR; Su YH; Yu SQ
J Ethnopharmacol; 2011 Dec; 138(3):731-6. PubMed ID: 22027446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
